We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
ARS Pharmaceuticals
SPRY
$405M
| $478 | ﹤0.01% |
38
+21
| +124% | +$253 |
2024 Q4
1 quarter
|
|
3227
iRadimed
IRMD
$1.14B
| $472 | ﹤0.01% |
9
| – | – |
2024 Q2
3 quarters
|
|
3228
Clover Health Investments
CLOV
$2.49B
| $470 | ﹤0.01% |
131
+46
| +54% | +$185 |
2024 Q4
1 quarter
|
|
3229
Profound Medical
PROF
$231M
| $466 | ﹤0.01% |
80
+50
| +167% | +$345 |
2022 Q1
12 quarters
|
|
3230
Virtus Convertible & Income Fund
NCV
$339M
| $465 | ﹤0.01% |
36
-1
| -3% | -$14 |
2024 Q2
3 quarters
|
|
3231
Primoris Services
PRIM
$3.97B
| $459 | ﹤0.01% |
8
-20
| -71% | -$1.45K |
2024 Q4
1 quarter
|
|
3232
Organogenesis Holdings
ORGO
$143M
| $458 | ﹤0.01% |
106
+18
| +20% | +$73 |
2024 Q4
1 quarter
|
|
3233
Klaviyo
KVYO
$5.15B
| $454 | ﹤0.01% |
+15
| New | +$605 |
2025 Q1
0 quarters
|
|
3234
Sports Entertainment Gaming Global Corp
SEGG
$4.89M
| $445 | ﹤0.01% |
7
| – | – |
2022 Q2
11 quarters
|
|
3235
Allot
ALLT
$446M
| $440 | ﹤0.01% |
+77
| New | +$539 |
2025 Q1
0 quarters
|
|
3236
Heron Therapeutics
HRTX
$71.5M
| $440 | ﹤0.01% |
200
| – | – |
2020 Q1
20 quarters
|
|
3237
Quantum Computing Inc
QUBT
$1.55B
| $440 | ﹤0.01% |
55
+48
| +686% | +$422 |
2024 Q4
1 quarter
|
|
3238
Flywire
FLYW
$2.35B
| $437 | ﹤0.01% |
+46
| New | +$724 |
2025 Q1
0 quarters
|
|
3239
GoodRx Holdings
GDRX
$1.19B
| $437 | ﹤0.01% |
99
+79
| +395% | +$371 |
2023 Q4
5 quarters
|
|
3240
The Honest Company
HNST
$549M
| $437 | ﹤0.01% |
+93
| New | +$533 |
2025 Q1
0 quarters
|
|
3241
Atlas Energy Solutions
AESI
$1.29B
| $428 | ﹤0.01% |
24
-1
| -4% | -$21 |
2024 Q2
3 quarters
|
|
3242
DELISTED
AvidXchange
AVDX
| $416 | ﹤0.01% |
49
-65
| -57% | -$601 |
2022 Q4
9 quarters
|
|
3243
Clearfield
CLFD
$407M
| $416 | ﹤0.01% |
14
-1,920
| -99% | -$64.2K |
2022 Q2
11 quarters
|
|
3244
Custom Truck One Source
CTOS
$2.09B
| $414 | ﹤0.01% |
+98
| New | +$473 |
2025 Q1
0 quarters
|
|
3245
DXP Enterprises
DXPE
$2.76B
| $411 | ﹤0.01% |
5
| – | – |
2024 Q4
1 quarter
|
|
3246
Centuri Holdings
CTRI
$2B
| $410 | ﹤0.01% |
+25
| New | +$481 |
2025 Q1
0 quarters
|
|
3247
Inseego
INSG
$73M
| $409 | ﹤0.01% |
50
| – | – |
2020 Q2
19 quarters
|
|
3248
CoreCivic
CXW
$3.09B
| $406 | ﹤0.01% |
20
| – | – |
2023 Q2
7 quarters
|
|
3249
Star Bulk Carriers
SBLK
$3.25B
| $405 | ﹤0.01% |
26
| – | – |
2024 Q2
3 quarters
|
|
3250
Critical Metals Corp
CRML
$1.02B
| $404 | ﹤0.01% |
+291
| New | +$1.33K |
2025 Q1
0 quarters
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.